Unknown

Dataset Information

Plasma proteomics improves prediction of coronary plaque progression.


ABSTRACT:

Aims

Coronary computed tomography angiography (CCTA) offers detailed imaging of plaque burden and composition, with plaque progression being a key determinant of future cardiovascular events. As repeated CCTA scans are burdensome and costly, there is a need for non-invasive identification of plaque progression. This study evaluated whether combining proteomics with traditional risk factors can detect patients at risk for accelerated plaque progression.

Methods and results

This long-term follow-up study included 97 participants who underwent two CCTA scans and plasma proteomics analysis using the Olink platform. Accelerated plaque progression was defined as rates above the median for percent atheroma volume (PAV), percent non-calcified plaque volume (NCPV), and percent calcif

SUBMITTER: Kraaijenhof JM 

PROVIDER: S-EPMC11879226 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature